Hyperhemolysis syndrome in patients with sickle cell disease

Mara Banks, James Shikle

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Sickle cell disease is a genetic disease commonly affecting people of African, Indian, and Mediterranean descent. Patients with this chronic disease often require lifelong red blood cell transfusions. Formation of alloantibodies and autoantibodies are well-known complications that can arise with multiple transfusions. Another rare, but serious complication associated with transfusion is hyperhemolysis syndrome. The acquisition of new and/or rare alloantibodies can make it more difficult to find compatible blood products for patients with sickle cell disease. Genotyping and national donor registries are useful tools for finding appropriate blood products for these patients. This review will describe the clinical and laboratory findings of sickle cell disease, including hyperhemolysis syndrome. The challenges associated with locating compatible blood for patients with various red blood cell antibodies will be reviewed.

Original languageEnglish (US)
Pages (from-to)1425-1427
Number of pages3
JournalArchives of Pathology and Laboratory Medicine
Volume142
Issue number11
DOIs
StatePublished - Nov 2018

Fingerprint

Sickle Cell Anemia
Isoantibodies
Erythrocyte Transfusion
Inborn Genetic Diseases
Autoantibodies
Registries
Chronic Disease
Erythrocytes
Tissue Donors
Antibodies

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Hyperhemolysis syndrome in patients with sickle cell disease. / Banks, Mara; Shikle, James.

In: Archives of Pathology and Laboratory Medicine, Vol. 142, No. 11, 11.2018, p. 1425-1427.

Research output: Contribution to journalReview article

@article{07e313bf031c4bdea864e63dfe1b635a,
title = "Hyperhemolysis syndrome in patients with sickle cell disease",
abstract = "Sickle cell disease is a genetic disease commonly affecting people of African, Indian, and Mediterranean descent. Patients with this chronic disease often require lifelong red blood cell transfusions. Formation of alloantibodies and autoantibodies are well-known complications that can arise with multiple transfusions. Another rare, but serious complication associated with transfusion is hyperhemolysis syndrome. The acquisition of new and/or rare alloantibodies can make it more difficult to find compatible blood products for patients with sickle cell disease. Genotyping and national donor registries are useful tools for finding appropriate blood products for these patients. This review will describe the clinical and laboratory findings of sickle cell disease, including hyperhemolysis syndrome. The challenges associated with locating compatible blood for patients with various red blood cell antibodies will be reviewed.",
author = "Mara Banks and James Shikle",
year = "2018",
month = "11",
doi = "10.5858/arpa.2017-0251-RS",
language = "English (US)",
volume = "142",
pages = "1425--1427",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "11",

}

TY - JOUR

T1 - Hyperhemolysis syndrome in patients with sickle cell disease

AU - Banks, Mara

AU - Shikle, James

PY - 2018/11

Y1 - 2018/11

N2 - Sickle cell disease is a genetic disease commonly affecting people of African, Indian, and Mediterranean descent. Patients with this chronic disease often require lifelong red blood cell transfusions. Formation of alloantibodies and autoantibodies are well-known complications that can arise with multiple transfusions. Another rare, but serious complication associated with transfusion is hyperhemolysis syndrome. The acquisition of new and/or rare alloantibodies can make it more difficult to find compatible blood products for patients with sickle cell disease. Genotyping and national donor registries are useful tools for finding appropriate blood products for these patients. This review will describe the clinical and laboratory findings of sickle cell disease, including hyperhemolysis syndrome. The challenges associated with locating compatible blood for patients with various red blood cell antibodies will be reviewed.

AB - Sickle cell disease is a genetic disease commonly affecting people of African, Indian, and Mediterranean descent. Patients with this chronic disease often require lifelong red blood cell transfusions. Formation of alloantibodies and autoantibodies are well-known complications that can arise with multiple transfusions. Another rare, but serious complication associated with transfusion is hyperhemolysis syndrome. The acquisition of new and/or rare alloantibodies can make it more difficult to find compatible blood products for patients with sickle cell disease. Genotyping and national donor registries are useful tools for finding appropriate blood products for these patients. This review will describe the clinical and laboratory findings of sickle cell disease, including hyperhemolysis syndrome. The challenges associated with locating compatible blood for patients with various red blood cell antibodies will be reviewed.

UR - http://www.scopus.com/inward/record.url?scp=85056329897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056329897&partnerID=8YFLogxK

U2 - 10.5858/arpa.2017-0251-RS

DO - 10.5858/arpa.2017-0251-RS

M3 - Review article

C2 - 30407854

AN - SCOPUS:85056329897

VL - 142

SP - 1425

EP - 1427

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 11

ER -